As VPAC1 seems to be a marker of disease activity in EA, we decided to compare it with 2 acute phase reactants that are commonly used to monitor disease activity in RA, namely, the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). This evidence concerns the gene VIPR1 and rheumatoid arthritis.